BCV
ALNY icon

Banque Cantonale Vaudoise’s Alnylam Pharmaceuticals ALNY Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Sell
5,978
-5,059
-46% -$1.72M 0.07% 247
2025
Q4 		$4.39M Buy
11,037
+6,177
+127% +$2.73M 0.16% 122
2025
Q3 		$2.22M Sell
4,860
-883
-15% -$360K 0.08% 234
2025
Q2 		$1.87M Buy
5,743
+2,015
+54% +$558K 0.08% 247
2025
Q1 		$1.01M Buy
+3,728
New +$958K 0.04% 354
2024
Q3 		$1.53M Buy
+5,560
New +$1.45M 0.06% 269
2023
Q4 		– Sell
-2,058
Closed -$365K – 1019
2023
Q3 		$365K Sell
2,058
-2,842
-58% -$542K 0.02% 545
2023
Q2 		$931K Buy
4,900
+2,100
+75% +$416K 0.04% 361
2023
Q1 		$561K Hold
2,800
– – 0.03% 427
2022
Q4 		$666K Sell
2,800
-3,500
-56% -$747K 0.03% 389
2022
Q3 		$1.26M Buy
6,300
+3,500
+125% +$668K 0.07% 268
2022
Q2 		$408K Hold
2,800
– – 0.02% 545
2022
Q1 		$458K Hold
2,800
– – 0.02% 582
2021
Q4 		$475K Sell
2,800
-300
-10% -$55.8K 0.02% 597
2021
Q3 		$585K Hold
3,100
– – 0.03% 526
2021
Q2 		$526K Hold
3,100
– – 0.02% 580
2021
Q1 		$438K Buy
3,100
+1,700
+121% +$256K 0.02% 575
2020
Q4 		$182K Sell
1,400
-2,400
-63% -$320K 0.01% 749
2020
Q3 		$553K Buy
3,800
+1,001
+36% +$142K 0.04% 408
2020
Q2 		$414K Buy
2,799
+299
+12% +$40.3K 0.03% 439
2020
Q1 		$272K Hold
2,500
– – 0.02% 541
2019
Q4 		$288K Buy
+2,500
New +$249K 0.02% 626

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's ALNY Position: Q1 2026 in Review

Banque Cantonale Vaudoise reduced its Alnylam Pharmaceuticals (ALNY) stake by 46% in Q1 2026, selling an estimated $1.72M and leaving 5,978 shares worth $1.98M. The position accounts for 0.07% of the portfolio, ranked #247.

Banque Cantonale Vaudoise first reported a position in ALNY in Q4 2019 and has held it in 22 quarters since. The position peaked at $4.39M in Q4 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Banque Cantonale Vaudoise held 5,978 shares of Alnylam Pharmaceuticals worth $1.98M as of Q1 2026.
  • Banque Cantonale Vaudoise sold 5,059 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.72M.
  • Alnylam Pharmaceuticals made up 0.07% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #247 holding.
  • Banque Cantonale Vaudoise first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 22 quarters since.
  • Banque Cantonale Vaudoise's Alnylam Pharmaceuticals position peaked at $4.39M in Q4 2025.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.